Dr Siddhartha Mahanty
Clinical (Associate Professor)
Department of Infectious Diseases
113 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Spatial distribution of and socio-ecological risk factors for strongyloidiasis in Australia
DOI: 10.1016/j.jinf.2026.1066772026
Journal article
Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggest imprinting to the ancestral strain of SARS-CoV-2
DOI: 10.1128/mbio.03221-252025
Journal article
Genetic markers of enhanced functional antibody responses to COVID-19 vaccination
DOI: 10.1016/j.vaccine.2025.1273792025
Journal article
Cestode larvae excite host neuronal circuits via glutamatergic signalling.
DOI: 10.7554/eLife.881742024
Research grants (ARC, NHMRC, MRFF)
Ending the Neglect – Setting the Platform for Strongyloidiasis Elimination in Australia
2020
Research Contracts
BEATING COVID-19 – Urgent Research to Minimise the Health, Social and Economic Impacts of COVID-19
2020
Research Grant
NIAID Centers of Excellence in Influenza Research and Surveillance (URF AWDC528132)
RECENT SCHOLARLY WORKS
2025
Journal article
Cestode larvae excite host neuronal circuits via glutamatergic signalling
DOI: 10.7554/elife.88174.32025
Journal article
The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose
DOI: 10.1016/j.jinf.2025.1064472025
Journal article
Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines
DOI: 10.3389/fimmu.2025.14870662025
Journal article
Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination
DOI: 10.1038/s41541-025-01268-w2022
Journal article
Tuberculosis mortality: quantifying agreement in clinical cause of death assessments
DOI: 10.1111/1753-6405.132042022
Journal article
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
DOI: 10.1021/acsnano.2c04543
RECENT PROJECTS
2020
Research Grant
NIAID Centers of Excellence in Influenza Research and Surveillance (URF AWDC528132)